Global Peptide CDMO Competitive Landscape Professional Research Report 2024

Global Peptide CDMO Competitive Landscape Professional Research Report 2024

Research Summary

A Peptide Contract Development and Manufacturing Organization (CDMO) is a specialized company that offers comprehensive services for the development, production, and manufacturing of peptides. Peptides are short chains of amino acids that play a crucial role in various biological processes and are used in a wide range of applications, including pharmaceuticals, diagnostics, and research. Peptide CDMOs work with pharmaceutical and biotechnology companies to provide expertise in peptide synthesis, process development, quality control, and large-scale manufacturing. They can assist in all stages of peptide development, from early research and development to the commercial production of peptide-based products. Peptide CDMOs play a vital role in accelerating the development of peptide-based drugs and therapies, ensuring high-quality production, and meeting the regulatory requirements of the pharmaceutical industry.

According to DIResearch's in-depth investigation and research, the global Peptide CDMO market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Peptide CDMO include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Peptide CDMO. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Peptide CDMO market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptide CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Peptide CDMO Include:

Bachem

PolyPeptide

CordenPharma

AmbioPharm

USV Peptides

Thermofischer

Bio Basic

JPT

Genscript

Xinbang Pharma

ScinoPharm

SN Biopharm

CBL

Piramal Pharma

CPC Scientific

Peptide CDMO Product Segment Include:

APIs and Intermediates

FDF

Peptide CDMO Product Application Include:

Commercial

Academic Research

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Peptide CDMO Industry PESTEL Analysis

Chapter 3: Global Peptide CDMO Industry Porter’s Five Forces Analysis

Chapter 4: Global Peptide CDMO Major Regional Market Size and Forecast Analysis

Chapter 5: Global Peptide CDMO Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Peptide CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Peptide CDMO Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources